HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The rise of a new GABA pharmacology.

Abstract
Key developments in GABA pharmacology over the last 30 years are reviewed with special reference to the advances pioneered by Erminio Costa. His passion for innovative science, and his quest for novel therapies for psychiatric disorders are particularly apparent in his fundamental contributions to the field of GABA research, with a focus on anxiety disorders and schizophrenia. He was a cofounder of the GABAergic mechanism of action of benzodiazepines. He envisaged partial agonists as novel anxiolytics. He identified DBI (diazepam binding inhibitor) as endogenous agonist of neurosteroidogenesis with multiple CNS effects and he pointed to the developmental origin of GABAergic dysfunctions in schizophrenia through his discovery of a reelin deficit, all this in collaboration with Sandro Guidotti. Today, the GABA pharmacology comprises selective hypnotics, non-sedative anxiolytics, memory enhancers and powerful analgesics. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.
AuthorsHanns Möhler
JournalNeuropharmacology (Neuropharmacology) Vol. 60 Issue 7-8 Pg. 1042-9 (Jun 2011) ISSN: 1873-7064 [Electronic] England
PMID21035473 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Analgesics
  • Diazepam Binding Inhibitor
  • GABA Agents
  • Hypnotics and Sedatives
  • Receptors, GABA-A
  • Reelin Protein
  • Benzodiazepines
  • gamma-Aminobutyric Acid
  • RELN protein, human
Topics
  • Analgesics (pharmacology, therapeutic use)
  • Benzodiazepines (agonists, antagonists & inhibitors, chemistry, pharmacology)
  • Diazepam Binding Inhibitor (metabolism, pharmacology, therapeutic use)
  • GABA Agents (pharmacology, therapeutic use)
  • Humans
  • Hypnotics and Sedatives (antagonists & inhibitors, metabolism, pharmacology)
  • Panic Disorder (drug therapy, physiopathology)
  • Receptors, GABA-A (drug effects, genetics, physiology)
  • Reelin Protein
  • gamma-Aminobutyric Acid (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: